Broncus Holding Corporation
HKSE: 2216.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Hong Xu
- Employees
- 200
- Headquarters
- Hangzhou, China
- IPO year
- 2021
- Market cap
- HK$552.9M
- Website
- https://www.broncus.com
Loading 2216…
Loading profile data…Frequently asked questions about 2216
What does Broncus Holding Corporation (2216.HK) do?
Broncus Holding Corporation, a medical device company, focuses on the development of interventional pulmonology products in Mainland China, the European Union, the United States, and internationally. The company provides navigation products, such as LungPoint Virtual Bronchoscopic Navigation, a computer-assisted image-based navigation software s...
Where does 2216.HK trade?
Broncus Holding Corporation (2216.HK) trades on the Hong Kong Stock Exchange.
What sector is 2216.HK in?
Broncus Holding Corporation (2216.HK) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Broncus Holding Corporation?
Hong Xu is the chief executive officer of Broncus Holding Corporation (2216.HK).
Where is Broncus Holding Corporation headquartered?
Broncus Holding Corporation is headquartered in China.
Does 2216.HK pay a dividend?
Broncus Holding Corporation (2216.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 2216.HK go public?
Broncus Holding Corporation (2216.HK) completed its initial public offering in 2021.